Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pegasys peginterferon alfa-2a: Began Trial

(BLA submitted, B6)

F. Hoffmann-La Roche Ltd. (SWX:ROCZ), Basel,

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE